The University Of Texas Health Science Center At San Antonio

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 1

Completed

Conditions: Squamous Cell Carcinoma
Head and Neck Cancer

Interventions: Biological: EGFR Antisense DNA

First Posted Date: 2012-05-07

Last Posted Date: 2022-09-21

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 6

Registration Number: NCT01592721

Locations: 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸
Cancer Therapy and Research Center at UTHSCSA, San Antonio, Texas, United States

Acute Effect of Exenatide on Brain Glucose Metabolism

Phase 4

Completed

Conditions: Impaired Glucose Tolerance (IGT)
Diabetes

Interventions: Drug: Exenatide
Drug: Placebo

First Posted Date: 2012-05-01

Last Posted Date: 2017-11-24

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 15

Registration Number: NCT01588418

Locations: 🇺🇸
Texas Diabetes Institute and UTHSCSA, San Antonio, Texas, United States

Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer

Phase 2

Completed

Conditions: Carcinoma, Squamous Cell of Head and Neck

Interventions: Drug: Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed by Concurrent Radiation, Cisplatin, Cetuximab and Bevacizumab (XPE-A), surgery

First Posted Date: 2012-05-01

Last Posted Date: 2024-02-14

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 3

Registration Number: NCT01588431

Locations: 🇺🇸
Cancer Therapy and Research Center at UTHSCSA, San Antonio, Texas, United States

Ridge Preservation After Tooth Extraction Using Cortical Versus Cancellous Freeze Dried Bone Allograft

Not Applicable

Completed

Conditions: Tooth Extraction

Interventions: Device: Cancellous FDBA
Device: cortical FDBA

First Posted Date: 2012-05-01

Last Posted Date: 2015-10-22

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 40

Registration Number: NCT01588444

Locations: 🇺🇸
UT Health Science Center Dental School, San Antonio, Texas, United States

Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)

Phase 4

Completed

Conditions: Type 2 Diabetes
Coronary Heart Disease

Interventions: Drug: pioglitazone

First Posted Date: 2012-05-01

Last Posted Date: 2017-12-06

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 130

Registration Number: NCT01588470

Sequential Multiple Assignment Treatment for Bipolar Disorder

Phase 4

Completed

Conditions: Bipolar I Disorder
Bipolar II Disorder

Interventions: Drug: Divalproex
Drug: Lithium
Drug: Quetiapine
Drug: Lamotrigine

First Posted Date: 2012-05-01

Last Posted Date: 2020-08-19

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 112

Registration Number: NCT01588457

Locations: 🇺🇸
Case Western Reserve University, Cleveland, Ohio, United States
🇺🇸
University of Texas Health Science Center, San Antonio, Texas, United States

A Prospective Study: Alveolar Ridge Augmentation Using Tenting Screws, Acellular Dermal Matrix and Combination Particulate Grafts

Not Applicable

Completed

Conditions: Dental Alveolus
Oral Surgical Procedures, Preprosthetic

Interventions: Device: allograft alone
Device: allograft with autograft

First Posted Date: 2012-04-06

Last Posted Date: 2018-01-02

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 34

Registration Number: NCT01572298

Locations: 🇺🇸
University of texas Health Science Center Dental School at San Antonio, San Antonio, Texas, United States

Treatment Development Targeting Severe and Persistent Negative Symptoms

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Behavioral: MOVE

First Posted Date: 2012-03-12

Last Posted Date: 2016-01-12

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 96

Registration Number: NCT01550666

Locations: 🇺🇸
The Center for Health Care Services, San Antonio, Texas, United States

Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action

Not Applicable

Completed

Conditions: Insulin Sensitivity
Multiple Mitochondrial Dysfunctions Syndrome

Interventions: Drug: Placebo
Drug: Dapagliflozin

First Posted Date: 2011-09-23

Last Posted Date: 2019-10-29

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 18

Registration Number: NCT01439854

Locations: 🇺🇸
Diabetes Division, UTHSCSA, San Antonio, Texas, United States

Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector

Phase 2

Completed

Conditions: Cancer Other Than Leukemia

Interventions: Drug: Arsenic Trioxide

First Posted Date: 2011-09-02

Last Posted Date: 2017-12-13

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 50

Registration Number: NCT01428128

Locations: 🇺🇸
The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy